Asthma and Allergy Screening AA2000 (Cross Sectional)
NCT04727112 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 493
Last updated 2021-01-27
Summary
Asthma screening of 493 asthma patients
Conditions
Interventions
- DRUG
-
Usual care versus primary care
RCT study
Sponsors & Collaborators
-
Bispebjerg Hospital
lead OTHER
Principal Investigators
-
Vibeke Backer, MD · Bispebjerg Hospital
Eligibility
- Min Age
- 15 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2003-01-31
- Completion
- 2004-01-31
More Related Trials
-
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
NCT02574975 ·Status: UNKNOWN ·Phase: PHASE4
-
Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics
NCT00252291 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of ARRY-502 in Patients With Persistent Asthma
NCT01561690 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old
NCT02787967 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
NCT01890161 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma
NCT01078688 ·Status: COMPLETED
-
Asthma Control Study 2011
NCT01298739 ·Status: COMPLETED
-
Seinäjoki Adult Asthma Study
NCT02733016 ·Status: COMPLETED
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 ·Status: COMPLETED
-
General Risk Factors and Inflammatory Determinants in Older Patients With Asthma
NCT03278561 ·Status: COMPLETED
-
Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
NCT00995800 ·Status: COMPLETED ·Phase: PHASE2
-
Glasgow Asthma and Allergy Study
NCT01618318 ·Status: COMPLETED
-
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00812773 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
NCT00517816 ·Status: COMPLETED ·Phase: PHASE1
-
Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069
NCT01890148 ·Status: COMPLETED ·Phase: PHASE1
-
Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR)
NCT01549483 ·Status: COMPLETED
-
Study in Mild Asthmatic Patients
NCT00748306 ·Status: COMPLETED ·Phase: PHASE2
-
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
NCT00284856 ·Status: COMPLETED ·Phase: PHASE3
-
A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma
NCT00130351 ·Status: COMPLETED ·Phase: PHASE3
-
Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma
NCT02177370 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients
NCT00557141 ·Status: UNKNOWN
-
A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)
NCT00401596 ·Status: COMPLETED ·Phase: PHASE3
-
Academic Detailing About Asthma
NCT05442307 ·Status: UNKNOWN ·Phase: NA
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 2
NCT01224951 ·Status: UNKNOWN ·Phase: NA